Literature DB >> 23137154

Olanzapine in schizophrenia and affective disorders.

Juan Undurraga, Eduard Vieta, Mauricio Tohen, Francesc Colom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23137154     DOI： 10.1007/bf03262005

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  3 in total

1.  Comparison of treatment-emergent extrapyramidal symptoms in patients with bipolar mania or schizophrenia during olanzapine clinical trials.

Authors:  Patrizia A Cavazzoni; Paul H Berg; Ludmila A Kryzhanovskaya; Susan D Briggs; Tamra E Roddy; Mauricio Tohen; John M Kane
Journal:  J Clin Psychiatry       Date:  2006-01       Impact factor: 4.384

Review 2.  Adverse effects of antipsychotics as outcome measures.

Authors:  Samantha Hamer; Peter M Haddad
Journal:  Br J Psychiatry Suppl       Date:  2007-08

3.  Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysis.

Authors:  Hoda Moteshafi; Simon Zhornitsky; Sarah Brunelle; Emmanuel Stip
Journal:  Drug Saf       Date:  2012-10-01       Impact factor: 5.606
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.